Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

2023142 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 402, Issue 10400, pp. 472-483

Field-Weighted Citation Impact: 28.52